• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Fetal reduction of triplets increases duration of gestation

byDenise PongandLeah Hawkins Bressler, MD, MPH
April 27, 2014
in Obstetrics
Reading Time: 2 mins read
Oral glucose tolerance test preferred for pre-diabetes screening in PCOS
Share on FacebookShare on Twitter

Image: PD 

1. Women with trichorionic triplets who underwent multifetal pregnancy reduction (MFPR) delivered at a greater gestational age than women with ongoing triplet pregnancy. 

2. Women who underwent reduction were more likely to have all fetuses intended to survive living at 1 week postpartum than women with triplet pregnancies. 

Evidence Rating Level: 2 (Good) 

Study Rundown: This study found that reduction of trichorionic triplet pregnancies to two fetuses was associated with longer gestations but had no impact on perinatal mortality. While there is substantial literature supporting the use of MFPR in pregnancies with four or more fetuses, its use in triplet pregnancies has not been well-studied. The present work suggests that MFPR also increases median gestational age in trichorionic triplet pregnancies.

This study is limited by retrospective design, small sample size, and differences in baseline characteristics between groups. Future studies that directly measure neonatal morbidity and longer term outcomes are needed to more fully characterize potential benefits of MFPR.

RELATED REPORTS

No Content Available

Click to read the study in AJOG

Relevant Reading: Risk of miscarriage and early preterm birth in trichorionic triplet pregnancies with embryo reduction versus expectant management

In-Depth [retrospective cohort study]: This study evaluated differences in pregnancy outcomes between women with trichorionic triplet pregnancies who underwent reduction to 2 fetuses (n=86), women with ongoing triplet pregnancies (n=44), and women with primary twin pregnancies (n=824). Outcomes evaluated included gestational age, delivery <24 weeks, delivery <32 weeks, birth weight and overall neonatal morbidity.

Median gestational age at delivery was greatest for primary twins (37.1 weeks), next greatest for triplets reduced to twins (36.1 weeks) and least for ongoing triplets (33.3 weeks) (p<0.001). Infant birth weight followed a similar trend (p<0.001). Compared to a twin pregnancy, women with triplets reduced to twins were no more likely to deliver at <24 weeks while those with an ongoing triplet pregnancy were (p=0.03). Women who underwent reduction were more likely to have all fetuses intended to survive living at 1 week postpartum than women with an ongoing triplet pregnancy (RR 1.3, CI 0.72-2.3).

More from this author: Interpartum HIV viral load suppression improves outcomes, Low hCG in early pregnancy associated with preeclampsia, First trimester biomarkers screen for congenital heart defects, Cerclage outcomes similar in singleton and twin pregnancies, New sepsis scoring system aids in predicting morbidity in obstetric patients

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: triplets
Previous Post

Reduced medical abortion anxiety, stress with text messaging intervention

Next Post

Four rash patterns common in adults with parvovirus infection

RelatedReports

No Content Available
Next Post
Four rash patterns common in adults with parvovirus infection

Four rash patterns common in adults with parvovirus infection

Indoor tanning associated with risky health behaviors in adolescents

Indoor tanning linked to high skin cancer risk in US and abroad

Minimal HIV adaptations to host in America over past twenty years

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • First messenger RNA influenza vaccine outperforms standard-dose vaccination
  • Few interventions improve posthospitalization follow-up for alcohol use disorder
  • Borderline-low hemoglobin levels linked to increased mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.